Myelomatous involvement of the central nervous system (CNS) is an uncommon complication that portends a poor prognosis in patients with multiple myeloma (MM). Limited data exist regarding the optimal management of CNS MM.
In the present case-control study, we examined the clinical presentation, diagnosis, treatment, and outcomes of CNS MM patients compared with a control group of MM patients without CNS involvement, matched by date of diagnosis and gender.